On Mintz's Health Law and Policy Matters blog, our colleague Joanne Hawana discussed the August 7 Warning Letter sent by FDA to the drug company Duchesnay, Inc., after Kim Kardashian praised the company’s morning sickness pill Diclegis in an Instagram post.
As described in the blog post, FDA objected to Kardashian’s social media post and called it false and misleading because the post failed to include information on significant limitations of the drug, as well as warnings and precautions. Because Kardashian is a paid spokesperson for Diclegis, her Instagram post promoting the drug must follow the same rules as other consumer advertisements for prescription drugs. The social media post was taken down immediately after Duchesnay received the Warning Letter. Read more about it here.